Antimicrobial Resistance Trends in <i>Streptococcus pneumoniae</i> and <i>Haemophilus influenzae</i>: A 13-Year SENTRY Surveillance Study from Turkey (2010 – 2023)

AuthorBelgin Altunen
AuthorGulsen Hazırolanen
AuthorDeniz Güren
OrcidBelgin Altun [0000-0002-8352-9692]en
OrcidGulsen Hazırolan [0000-0003-4546-9729]en
OrcidDeniz Gür [0000-0002-7504-8450]en
Issued Date2026-02-28en
AbstractBackground: Local surveillance of antimicrobial resistance is essential to guide empirical treatment strategies for respiratory tract infections. Long-term local data are particularly important in the context of rising global resistance and regional variations in antimicrobial susceptibility patterns, enabling clinicians to make informed empirical therapy decisions. Objectives: This study aimed to determine and compare antimicrobial resistance rates in Streptococcus pneumoniae (n = 335) and Haemophilus influenzae (n = 185) isolates obtained from community-acquired respiratory tract infections at Hacettepe University Hospital between 2010 and 2023. Methods: Streptococcus pneumoniae and H. influenzae isolates (one isolate per patient) recovered from sputum, tracheal aspirate, or bronchoalveolar lavage samples of patients with community-acquired pneumonia were included in the SENTRY surveillance program. Antimicrobial susceptibilities were determined by the microdilution method according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (2025) using cation-adjusted Mueller–Hinton broth supplemented with lysed horse blood. Results: Penicillin non-susceptibility (I+R) was 67.2% in S. pneumoniae isolates (42.7% intermediate, 24.5% resistant), while ampicillin resistance in H. influenzae was 13.0%. All S. pneumoniae isolates remained fully susceptible to meropenem, linezolid, and vancomycin. Ceftaroline resistance rates were 1.5% in S. pneumoniae and 3.2% in H. influenzae. No resistance to ceftriaxone was detected among H. influenzae isolates. Conclusions: High rates of penicillin and macrolide non-susceptibility in S. pneumoniae limit the empirical use of these agents in our setting. In contrast, ceftriaxone and respiratory fluoroquinolones remain highly effective options for the empirical treatment of community-acquired respiratory tract infections. These findings underscore the importance of continuous local surveillance to support rational antimicrobial therapy.en
DOIhttps://doi.org/10.5812/jjm-167264en
URIhttps://brieflands.com/journals/jjm/articles/167264en
Keyword<i>Streptococcus pneumoniae</i>en
KeywordHaemophilus ]nfluenzaeen
KeywordDrug Resistanceen
KeywordSurveillanceen
PublisherBrieflandsen
TitleAntimicrobial Resistance Trends in <i>Streptococcus pneumoniae</i> and <i>Haemophilus influenzae</i>: A 13-Year SENTRY Surveillance Study from Turkey (2010 – 2023)en
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jjm-19-2-167264-publish-pdf.pdf
Size:
276.53 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF